The cofounder and chief executive officer of Verve Therapeutics discussed the company’s pipeline.
Sekar Kethiresan, MD
Advertisement
Articles by Sekar Kethiresan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
CGTLive®’s Weekly Rewind – December 12, 2025
2
Around the Helix: Cell and Gene Therapy Company Updates – December 10, 2025
3
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
4
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial
5
